Vetter MH, Smrz SA, Copeland LJ, Cohn DE
Am J Obstet Gynecol in press Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients
Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients
with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19.
May 23, 2020 at 12:00 AM